ATX amplia therapeutics limited

Ann: Encouraging Updated Data from Pancreatic Cancer Trial, page-6

  1. 1,964 Posts.
    lightbulb Created with Sketch. 36
    what PR rate would / should we expect from SOC alone - 23%? We still have majority left to come of the 55 so hopefully it’s above 27% and the longevity extends beyond SOC. Was MPaCT late stage patients? The current ATX trial is all late stage so hopefully works even better at earlier stage. Apologies I should do some further research but asking as I know well informed re MPACT!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
20.0¢
Change
-0.020(9.09%)
Mkt cap ! $77.59M
Open High Low Value Volume
22.5¢ 25.0¢ 18.5¢ $3.489M 16.26M

Buyers (Bids)

No. Vol. Price($)
2 215000 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 189406 4
View Market Depth
Last trade - 16.10pm 30/06/2025 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.